Estrogen receptor variants in ER-positive basal-type breast cancers responding to therapy like ER-negative breast cancers

Immunohistochemically ER-positive HER2-negative (ER+HER2−) breast cancers are classified clinically as Luminal-type. We showed previously that molecular subtyping using the 80-gene signature (80-GS) reclassified a subset of ER+HER2− tumors to molecular Basal-type. We report here that molecular recla...

Descripción completa

Detalles Bibliográficos
Autores principales: Groenendijk, Floris H., Treece, Tina, Yoder, Erin, Baron, Paul, Beitsch, Peter, Audeh, William, Dinjens, Winand N. M., Bernards, Rene, Whitworth, Pat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472385/
https://www.ncbi.nlm.nih.gov/pubmed/31016233
http://dx.doi.org/10.1038/s41523-019-0109-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6472385/
https://www.ncbi.nlm.nih.gov/pubmed/31016233
http://dx.doi.org/10.1038/s41523-019-0109-7

Ejemplares similares